This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,893.64, is for the supply of CellCept 500 mg tablets, a medication used to prevent organ rejection in patients receiving kidney, heart, or liver transplants. The contract has a firm fixed price and an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4565134752 units of CellCept 500 mg tablets. The $7,967.40 firm fixed price contract has a ceiling value and an ultimate completion date of July 15, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a $16,028.49 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on December 3, 2024. The contract provides for the delivery of 4,566,590,738 units of CellCept 500 mg tablets by December 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation indicated. This contract award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 100S. The contract has a firm fixed price of $34,204.00 and an ultimate completion date of August 13, 2024. AmerisourceBergen is the prime contractor, and there is no set-aside designation mentioned. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of CellCept 500 mg tablets. The contract is valued at $13,867.86 and has an ultimate completion date of December 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,702.42, is for the delivery of CellCept 500 mg tablets to support military treatment facilities and federal healthcare programs. It is a firm fixed-price contract with an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,141.82 firm-fixed-price contract is for the supply of 4565697906 CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide medical supplies and medications to various...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $9,377.75, is for the delivery of 4564312523 - CELLCEPT 500 MG TABLET 100S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,417.59 firm fixed-price contract is for the supply of CellCept 200 mg/mL oral suspension, a pharmaceutical product used in the treatment of certain medical conditions. The contract has a period of performance through September 26, 2023. This order is placed against AmerisourceBergen's larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $39,863.84, is a Firm Fixed Price Delivery Order to provide 4,567,308,257 units of the drug CELLCEPT 500 MG TABLET 100S. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...